Key facts
- This page summarizes Gil Aharon's Form 4 filing for Neuraxis, INC (NRXS).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 17 Aug 2026, 18:23.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Award
Award
Additional SEC filing notes
Footnote F1
The number of shares of common stock issued as a dividend on the Series B Preferred Stock to Rosalind Master Fund L.P. and the Reporting Person were 40,068 and 2,226, respectively, and was determined by dividing the accrued and unpaid 8.5% cumulative dividends on the respective Series B Preferred Stock (from the investment date, through the applicable record or conversion date) by $2.38.
Footnote F2
These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer.
Footnote F3
Each Reporting Persons disclaims beneficial ownership over the shares except to the extent of his or its respective pecuniary interest therein.